Cancer-Associated Retinopathy (CAR Syndrome) with Antibodies Reacting with Retinal, Optic-Nerve, and Cancer CellsCharles E. Thirkill, John L. Keltner, Nancy K. Tyler et al.|New England Journal of Medicine|1989Cited by 241
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritisRobert C. Sergott, Johan van Beek, Jeffrey L. Bennett et al.|Journal of the Neurological Sciences|2015Cited by 81